Toenail Fungus Treatment
For toenail onychomycosis, oral terbinafine 250 mg daily for 12-16 weeks is the first-line treatment, as it achieves superior cure rates (70-80% for toenails) compared to all alternatives and has the lowest relapse rates. 1
Diagnostic Requirements Before Treatment
Do not start treatment without mycological confirmation 2. Obtain:
- Microscopy (KOH preparation) AND
- Fungal culture or PCR testing
This is critical because treatment is lengthy (3-4 months), expensive, and has potential adverse effects. Dermatophytes cause the vast majority of cases, but yeast and non-dermatophyte molds require different management 2.
Treatment Algorithm
For Dermatophyte Onychomycosis (Most Common)
First-line: Oral Terbinafine
- Dose: 250 mg daily for 12-16 weeks for toenails 1
- Complete cure rate: 55% at 72 weeks 1
- Mycological cure: 70-80% 2
- Long-term success: 46% remain cured at 5 years without retreatment 1
- Relapse rate: 23% (significantly lower than alternatives) 1
Second-line: Oral Itraconazole (if terbinafine contraindicated)
- Pulse dosing: 400 mg daily for 1 week per month × 3 pulses for toenails 1
- Continuous dosing: 200 mg daily for 12 weeks
- Complete cure rate: Only 26% at 72 weeks 1
- Relapse rate: 53% (more than double terbinafine) 1
For Mild to Moderate Disease (Distal Involvement Only)
Topical therapy alone is inferior to systemic treatment but acceptable when:
- Very distal nail involvement only
- Patient refuses or cannot tolerate oral therapy
- Contraindications to systemic treatment exist 2
Topical options (in order of effectiveness):
- Efinaconazole 10% solution - Most effective topical (RR 3.54 for complete cure vs vehicle) 3
- Tavaborole 5% solution - Second most effective (RR 7.40 for complete cure) 3
- Ciclopirox 8% lacquer - Less effective but established option 2, 3
For Candidal Onychomycosis (Uncommon in Toenails)
Itraconazole 400 mg daily for 1 week per month × 3-4 pulses is most effective 2
Critical Monitoring Requirements
Before starting terbinafine, obtain:
- Baseline liver function tests
- Complete blood count
Required in patients with:
- History of heavy alcohol consumption
- Hepatitis
- Pre-existing liver disease (terbinafine contraindicated in active/chronic liver disease) 1
Drug interactions to check:
- Terbinafine: Minimal interactions, but monitor drugs metabolized by CYP2D6 (tricyclic antidepressants, SSRIs, beta blockers, tamoxifen) 1, 4
- Itraconazole: Multiple CYP450 interactions - check all medications 1
Common Pitfalls and How to Avoid Them
Treatment failure (20-30% with terbinafine) is usually due to:
Subungual dermatophytoma - Dense fungal mass prevents drug penetration
- Solution: Partial nail removal/debridement before or during treatment 2
Poor compliance - Long treatment duration
- Solution: Emphasize that nail continues improving for months after stopping medication due to drug persistence in nail plate 2
Inadequate treatment duration
- Solution: Re-evaluate at 3-6 months; extend treatment if disease persists 1
Wrong organism - Non-dermatophyte or yeast misidentified
- Solution: Always confirm with culture before treating 2
Important Safety Warnings
Terbinafine:
- Rare but permanent taste disturbance - warn all patients 1
- Rare serious hepatotoxicity and Stevens-Johnson syndrome 1
- Generally well-tolerated: GI symptoms (49%), rash (23%) 1
Itraconazole:
- More drug interactions than terbinafine
- Contraindicated in heart failure
- Requires dose adjustment in renal impairment
Combination Therapy
Always combine systemic treatment with:
- Nail debridement/trimming - improves drug penetration and response 4
- Consider adding topical antifungal to systemic therapy for enhanced efficacy 2
When Topical Therapy Alone Is Insufficient
Topical treatment achieves much lower complete cure rates (even best agents like efinaconazole only achieve ~15-20% complete cure vs ~5% with vehicle) 3. Reserve topical monotherapy only for very distal disease or when oral therapy is absolutely contraindicated.